Aspen Targets Mounjaro Expansion in Africa Following Approval

Original Article by KabeloKhumalo | Business Day | 28 October 2025

Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.

Aspen’s Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.